ArticleMolecular therapy. Methods & clinical development2025

Silencing hepatic PCSK9 via novel chimeric AAV8 mitigates the progression of atherosclerosis by inhibiting inflammation in ApoE

Xiaocui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.